Institute For Clinical Research - DC District of Columbia, Washington 20037

Institute For Clinical Research entered the industry of Medical Labs in 1996 and has grown to employ 1 to 4 people, generating an annual revenue of $100.000 to $499.999. The NAICS classifies this business under the code 621511, which describes it as a Medical Labs. For further clarification, the SIC classifies this business under the code 8071 and described it as a Medical Labs. The business provides service to the B2C market.

To acquire more information, please contact Gamal El-Gamassy by calling (202) 994-0001 during business hours. You can also write to the business’ Single Location at 901 23rd St Nw # 5312n, Washington, District of Columbia DC 20037. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .

Company: Institute For Clinical Research
Representative: Gamal El-Gamassy
Place of Business: 901 23rd St Nw # 5312n, Washington, DC 20037
Contact Number: (202) 994-0001
Type of Service: Medical Labs
SIC Number: 8071
NAICS Number: 621511
Locality: Single Location
Market Type: B2C (Business to Consumer)
Began: 1996
Income/Year: $100.000 to $499.999
Laborers: 1 to 4
Share This Company:

Institute For Clinical Research is a company operating from District of Columbia, District of Columbia providing professional Medical Labs and relevant B2C variables. It was founded in 1996 and registered with the SIC code 8071 as Medical Labs, and with the NAICS code 621511 as Medical Labs.

With a current employee count of 1 to 4, Institute For Clinical Research has gone to report making $100.000 to $499.999 per annum on its journey towards growth. This company invites you to contact its representative Gamal El-Gamassy at (202) 994-0001 for related queries, or to locate its Single Location using the coordinates 38.901142,-77.049934.

The Single Location can also be found at the street address 901 23rd St Nw # 5312n in Washington, District of Columbia 20037 and can be engaged online through the company website at , the company Twitter , and Facebook page .